Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Kilitch Drugs (India) LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524500 NSE Symbol: KILITCH P/E (TTM) :30.26
ISIN Demat:INE729D01010 Div & Yield %:0 EPS (TTM) :11.85
Book Value (RS) :131.6037936 Market Cap (Rs Cr.):576.71 Face Value (RS) :10
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.110.100.090.070.04
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio1.171.021.201.552.02
Fixed Assets3.183.302.542.273.78
Inventory33.4624.4815.3011.8225.64
Debtors2.493.273.513.034.40
Interest Cover Ratio17.9118.418.174.6727.54
PBIDTM (%)18.6314.9211.909.0319.81
PBITM (%)17.4914.0110.277.1418.56
PBDTM (%)17.6514.1610.647.5019.14
CPM (%)14.4810.939.086.6814.78
APATM (%)13.3510.017.464.7913.53
ROCE (%)9.897.824.202.6712.22
RONW (%)8.416.183.321.929.25

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)